This is an overview of the USAID/Vietnam FY 2022 Tuberculosis (TB) Roadmap, implemented with FY 2021 budget

TABLES

The following tables illustrate the distribution by technical area of the USAID TB budget for Vietnam that will be used for the implementation of Vietnam’s FY22 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of Vietnam’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2).

Table 1: USAID Budget for Vietnam per Technical Area

Technical AreaUSAID TB budget for FY22USAID Percentage of TB budget for FY22
REACH$3,082,50044%
CURE$2,710,00039%
PREVENT$1,107,50016%
SUSTAINABLE SYSTEMS$100,0001%
TOTAL BUDGET:$7,000,000100%

Table 2: TB Core Indicators in Vietnam from 2015-2020 and Targets from 2021-2022

#Name2015201620172018201920202021*2022*
REACH: Increased DS- and DR-TB case notification
1TB Detection54.5%56.4%57.7%57.3%60.0%58%UNGA target: 138,100UNGA target: 128,500
2Bacteriological Diagnosis Coverage (Pulmonary TB)68.7%69.5%69.5%69.5%71.0%74%
3Childhood TB Notifications1241,6911,7161,6561,7041,396UNGA target: 6,100UNGA target: 6,000
4Drug-Resistant TB Notifications2,6303,1243,1213,1873,2473,714UNGA target: 7,300UNGA target: 8,460
5Private Sector TB Notifications3,2573,6173,707
6Contact Investigation Coverage**18,61267,391
CURE: High treatment success rate in DS- and DR-TB
7TB Treatment Success Rate***91.7%92.4%92.0%91.0%91.0%
8Drug-Resistant TB treatment Success Rate****74.5%67.8%68.0%71.0%
PREVENT: Prevent TB transmission and development
9TPT Coverage3,4748,6809,77525,88821,521UNGA target: 104,520UNGA target: 125,210
SUSTAINABLE SYSTEMS: Commitment and sustainability
10Proportion of Domestic Financing for TB28.9%20.0%15.0%

*Projected Targets: These represent the United Nations General Assembly High-Level Meeting targets (UNGA targets).
**Contact Investigation Coverage: based on limited available data from 2016 to 2020.. The shown data reflect only part of the indicator.
***TB Treatment Success Rate: newest data for 2019 cohort reported.
****Drug-Resistant TB Treatment Success Rate: newest data for 2018 cohort reported.